Neurotensin is a regulator of insulin secretion in pancreatic beta-cells

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 10, 2010, Pages 1681-1688

  Béraud Dufour, Sophie ^a,b   Abderrahmani, Amar ^c,d   Noel, Jacques ^a,b   Brau, Frédéric ^a,b   Waeber, Gérard ^c   Mazella, Jean ^a,b   Coppola, Thierry ^a,b  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Insulin secretion; Neurotensin; Pancreatic islet; PKC

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CALCIUM; CONOTOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; LEVOCABASTINE; NEUROTENSIN; NEUROTENSIN RECEPTOR; NITRENDIPINE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL SECRETION; DRUG EFFECT; DRUG INHIBITION; EXOCYTOSIS; FEMALE; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION;

ANIMALS; CALCIUM SIGNALING; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPROTECTION; ENZYME ACTIVATION; INSULIN; INSULIN-SECRETING CELLS; NEUROTENSIN; PIPERIDINES; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; PYRAZOLES; QUINOLINES; RATS; RECEPTORS, NEUROTENSIN;

EID: 77956184011     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.06.018     Document Type: Article

References (43)

1. Abderrahmani A., Cheviet S., Ferdaoussi M., Coppola T., Waeber G., Regazzi R ICER induced by hyperglycemia represses the expression of genes essential for insulin exocytosis. EMBO J 2006, 25(5):977-986.
2. Ashcroft F.M., Rorsman P Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989, 54(2):87-143.
3. Beraud-Dufour S., Coppola T., Massa F., Mazella J. Neurotensin receptor-2 and -3 are crucial for the anti-apoptotic effect of neurotensin on pancreatic beta-TC3 cells. Int J Biochem Cell Biol 2009, 41(12):2398-2402.
4. Bozou J.C., Amar S., Vincent J.P., Kitabgi P Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase. Mol Pharmacol 1986, 29(5):489-496.
5. Bozou J.C., Rochet N., Magnaldo I., Vincent J.P., Kitabgi P Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem J 1989, 264(3):871-878.
6. Carraway R., Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973, 248(19):6854-6861.
7. Carraway R.E., Demers L.M., Leeman S.E. Hyperglycemic effect of neurotensin, a hypothalamic peptide. Endocrinology 1976, 99(6):1452-1462.
8. Carraway R.E., Gui X., Cochrane DE Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. J Pharmacol Exp Ther 2003, 307(2):640-650.
9. Clancy B.M., Czech MP Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem 1990, 265(21):12434-12443.
10. Coppola T., Beraud-Dufour S., Antoine A., Vincent J.P., Mazella J. Neurotensin protects pancreatic beta cells from apoptosis. Int J Biochem Cell Biol 2008, 40(10):2296-2302.
11. Dolais-Kitabgi J., Kitabgi P., Brazeau P., Freychet P Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets. Endocrinology 1979, 105(1):256-260.
12. Dubuc I., Sarret P., Labbe-Jullie C., Botto J.M., Honore E., Bourdel E., et al. Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci 1999, 19(1):503-510.
13. Eliasson L., Renstrom E., Ammala C., Berggren P.O., Bertorello A.M., Bokvist K., et al. PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science 1996, 271(5250):813-815.
14. Gullo L., Pezzilli R., Tomassetti P., de Giorgio R. Plasma cholecystokinin and neurotensin after an ordinary meal in humans. A prolonged time study. Gastroenterol Clin Biol 1998, 22(1):25-28.
15. Hammer R.A., Carraway R.E., Leeman S.E. Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components. J Clin Invest 1982, 70(1):74-81.
16. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000, 49(11):1751-1760.
17. Ishida T., Kawamura K., Goto A., Nishina Y., Takahara J. Comparison studies of neurotensin and xenopsin upon pancreatic secretion in the dog [proceedings]. Metabolism: clinical and experimental 1976, 25(11 Suppl. 1):1467.
18. Islam M.S., Kindmark H., Larsson O., Berggren P.O. Thiol oxidation by 2,2'-dithiodipyridine causes a reversible increase in cytoplasmic free Ca2+ concentration in pancreatic beta-cells. Role for inositol 1,4,5-trisphosphate-sensitive Ca2+ stores. Biochem J 1997, 321(Pt 2):347-354.
19. Kaneto A., Kaneko T., Kajinuma H., Kosaka K. Effects of substance P and neurotensin infused intrapancreatically on glucagon and insulin secretion. Endocrinology 1978, 102(2):393-401.
20. Martin S., Navarro V., Vincent J.P., Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 2002, 123(4):1135-1143.
21. Martin S., Vincent J.P., Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci 2003, 23(4):1198-1205.
22. Mazella J. Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking?. Cell Signal 2001, 13(1):1-6.
23. Mazella J., Vincent J.P. Functional roles of the NTS2 and NTS3 receptors. Peptides 2006, 27(10):2469-2475.
24. Mears D. Regulation of insulin secretion in islets of Langerhans by Ca(2+)channels. J Membr Biol 2004, 200(2):57-66.
25. Mendez C.F., Leibiger I.B., Leibiger B., Hoy M., Gromada J., Berggren P.O., et al. Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis. J Biol Chem 2003, 278(45):44753-44757.
26. Mogami H., Zhang H., Suzuki Y., Urano T., Saito N., Kojima I., et al. Decoding of short-lived Ca2+ influx signals into long term substrate phosphorylation through activation of two distinct classes of protein kinase C. J Biol Chem 2003, 278(11):9896-9904.
27. Morinville A., Martin S., Lavallee M., Vincent J.P., Beaudet A., Mazella J. Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells. Int J Biochem Cell Biol 2004, 36(11):2153-2168.
28. Munck Petersen C., Nielsen M.S., Jacobsen C., Tauris J., Jacobsen L., Gliemann J., et al. Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding. EMBO J 1999, 18(3):595-604.
29. Nesher R., Anteby E., Yedovizky M., Warwar N., Kaiser N., Cerasi E. Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 2002, 51(Suppl. 1):S68-73.
30. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427(6977):843-848.
31. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J Biol Chem 1997, 272(6):3599-3605.
32. Rojas E., Hidalgo J., Carroll P.B., Li M.X., Atwater I. A new class of calcium channels activated by glucose in human pancreatic beta-cells. FEBS Lett 1990, 261(2):265-270.
33. Schmitz-Peiffer C., Biden T.J. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 2008, 57(7):1774-1783.
34. Schmitz-Peiffer C., Laybutt D.R., Burchfield J.G., Gurisik E., Narasimhan S., Mitchell C.J., et al. Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 2007, 6(4):320-328.
35. Sutton R., Peters M., McShane P., Gray D.W., Morris PJ Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986, 42(6):689-691.
36. Taylor J.T., Huang L., Keyser B.M., Zhuang H., Clarkson C.W., Li M. Role of high-voltage-activated calcium channels in glucose-regulated beta-cell calcium homeostasis and insulin release. Am J Physiol Endocrinol Metab 2005, 289(5):E900-E908.
37. Tengholm A., Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 2009, 297(1-2):58-72.
38. Tsuboi T., da Silva Xavier G., Holz G.G., Jouaville L.S., Thomas A.P., Rutter G.A. Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem J 2003, 369(Pt 2):287-299.
39. Ukai M., Inoue I., Itatsu T. Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia. Endocrinology 1977, 100(5):1284-1286.
40. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 1999, 20(7):302-309.
41. Winzell M.S., Ahren B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Ther 2007, 116(3):437-448.
42. Wollheim C.B., Biden T.J. Signal transduction in insulin secretion: comparison between fuel stimuli and receptor agonists. Ann NY Acad Sci 1986, 488:317-333.
43. Zhang H., Nagasawa M., Yamada S., Mogami H., Suzuki Y., Kojima I. Bimodal role of conventional protein kinase C in insulin secretion from rat pancreatic beta cells. J Physiol 2004, 561(Pt 1):133-147.